Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage.

Overview

1. Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China
2. Academy of Medical Science, Zhengzhou University, Zhengzhou, China
3. Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada

Abstract

Background: Intracerebral haemorrhage (ICH) is characterised by high mortality and lethality with no effective treatment. Studying the pathophysiological mechanism of brain injury after ICH is expected to improve prognosis. Glimepiride (GPD) has neuroprotective effects in ischaemic stroke and Parkinson’s disease models. However, it is unclear whether GPD effectively reduces brain injury after ICH. Therefore, we evaluated GPD in acute brain injury in ICH mice and assessed its potential mechanisms.

Methods: C57BL/6 mice were injected with collagenase into the right striatum to induce ICH, and were euthanized after 3 days of GPD treatment (4 mg/kg/day). Brain tissues around the haematoma were collected for Western blot and microscopy analyses. The corner turn test, forelimb placing test and modified Garcia test were used to assess neurological functions during life.

Results: The effectiveness of GPD was demonstrated by improved neurological functions, decreased brain oedema and reduced haematoma volume. GPD upregulated ZO-1 and occludin expression while downregulating MMP-9, indicating that GPD protected the integrity of the blood-brain barrier. This was corroborated by the reduction of albumin and Evans blue leakage into the brain parenchyma of GPD-treated mice. Moreover, the anti-inflammatory efficacy of GPD was suggested by reduced Iba-1 and myeloperoxidase immunohistochemistry. GPD also decreased neuronal apoptosis, as evidenced by the upregulation of BCL-2, downregulation of BAX, and decreased number of TUNEL-positive cells.

Conclusion: In ICH injury, GPD protects the integrity of the blood-brain barrier, alleviates neuroinflammation, improves neurological functions, mitigates brain oedema, lessens haematoma volume, and inhibits the apoptosis of neural cells.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• figshare:32111700, at figshare; found in DataCite

Data availability statement

The original data generated in this study are included in the article/Supplementary Material and further inquiries can be directed to the corresponding authors.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 15 MeSH terms, 1 funder, 67 references.

Cite

This paper

Zhou, H., Wang, Q., Liu, Y., Zhang, X., Chen, Y., Guo, P., Yong, V. W., & Xue, M. (2026). Glimepiride alleviates blood-brain barrier disruption and neuroinflammation in mice with intracerebral haemorrhage. Annals of medicine, 58(1), 2663133. https://doi.org/10.1080/07853890.2026.2663133

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/brain/awaf435 [code]

SUR1-TRPM4 is expressed in human epilepsy and promotes neuron hyperactivity and seizures in rodents.

Journal: Brain : a journal of neurology

In common: histology / microscopy, mouse, cellular / molecular, 2 references

[2] doi:10.1155/humu/4033506

SELL Marks an Effector-Deficient CD8<sup>+</sup> T Cell Subset That Promotes Intracerebral Hemorrhage and Responds to Rutin Therapy.

Journal: Human mutation

In common: stroke, mouse, 2 references

[3] doi:10.1007/s10753-026-02456-z

Red Blood Cell-Derived Exosomes Deliver Complement C5 to Exacerbate Neuroinflammation and Neuronal Injury after Intracerebral Hemorrhage.

Journal: Inflammation

In common: stroke, histology / microscopy, mouse, 1 other category, 1 reference

[4] doi:10.1186/s12987-026-00825-2

Acute amyloid-β exposure disrupts insulin signaling in hCMEC/D3 blood-brain barrier endothelial cells.

Journal: Fluids and barriers of the CNS

In common: cellular / molecular, 2 references

[5] doi:10.1038/s41598-026-51310-7

BTK promotes neuroinflammation after intracerebral hemorrhage involving hub genes and alterations in microglial functions.

Journal: Scientific reports

In common: stroke, mouse, cellular / molecular, 1 reference

[6] doi:10.1038/s41467-026-74814-2

Structural mechanism of Necrocide 1 activation of human TRPM4 that triggers necrosis by sodium overload.

Journal: Nature communications

In common: histology / microscopy, mouse, cellular / molecular, 1 reference

[7] doi:10.1371/journal.pbio.3003608 [code]

Ischemic stroke triggers brain-wide synaptic remodeling within four hours.

Journal: PLoS biology

In common: stroke, histology / microscopy, cellular / molecular, 1 reference

[8] doi:10.1177/0271678x261471282 [code]

Single-cell analysis of microglia and monocyte dynamics uncovers distinct TNF-driven neuroimmune signatures in humans after intracerebral hemorrhage.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

In common: stroke, cellular / molecular, 1 reference

[9] doi:10.2147/ijgm.s581629

A Five-Gene PANoptosis Signature Correlates with Immune Infiltration and Secondary Brain Injury in Intracerebral Hemorrhage.

Journal: International journal of general medicine

In common: stroke, cellular / molecular, 1 reference

[10] doi:10.1186/s12929-026-01271-w

Lack of cortistatin drives neuroimmune and vascular dysfunction in brain ischemia.

Journal: Journal of biomedical science

In common: stroke, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.